177 Lu-DOTA-octreotate injection
| Name | Description |
|---|---|
| Indication | Treatment of Neuroendocrine tumours, which usually express high density of somatostatin receptors. |
| Production | Monday |
| Storage | 2° – 8° C |
| Expiration | 60 hours after labelling |
| Half Life | 6.65 days |
| Gamma Energy | 208 keV |
| 498 Kev (Beta Max 79%) | |
| Radionuclidic purity | >99% Lu-177 at expiry (< 0.1% Lu-177m at expiry) |
| Specific Activity | >10 Ci/mg at labelling |
| Composition | Lu177-DOTA-octreotate Sodium chloride |